Episodios

  • The Obesity Puzzle in the Era of GLP-1s: Meds, Maintenance, Mindset
    Oct 23 2025

    What happens after GLP-1s? Holly Wyatt discusses medication exit strategies, physiological adaptation, and future hope in obesity care. Learn how to transition from medication to mastery with purpose and self-efficacy.

    Timestamps:

    00:40 – GLP-1s

    03:36 – Stopping GLP-1s

    09:13 – Challenges

    09:56 – Exit strategies

    11:17 – Looking ahead

    Más Menos
    14 m
  • Bonus Episode: Expert Views on the Impact of the Updated Label for Cladribine Tablets, and what this Means for Clinical Practice in Multiple Sclerosis
    Oct 24 2025

    This promotional podcast has been initiated and funded by Merck, and a Merck product will be discussed. The intended audience is multiple sclerosis healthcare professionals in the UK only. The comments of the speakers in this podcast reflect their own opinions and are not necessarily those of Merck.

    Más Menos
    20 m
  • The Obesity Puzzle in the Era of GLP-1s: Sustainable Health Habits
    Oct 23 2025

    From nutrition to sleep and stress, this episode examines the real-life habits that make or break long-term success. Holly Wyatt explains how to build sustainable routines and redefine relapse without shame or failure.

    Timestamps:

    00:36 - Diets

    04:30 - Physical activity

    07:25 - Weight re-gain

    09:09 – Sleep/Stress

    11:52 – Public health

    Más Menos
    15 m
  • Bonus Episode: Podcast 2 Episode 1: Showcasing Becker Muscular Dystrophy: Insights from Natural History
    Oct 22 2025

    The following podcasts were funded by Edgewise Therapeutics.

    Disclaimers: The views and opinions expressed in these podcasts are those of the individual speakers and do not necessarily reflect those of Edgewise Therapeutics or EMJ.

    The speakers received honoraria for participating in this recording.

    This episode offers experts insights from with Dr. Amit Sachdev. It explores Becker muscular dystrophy (Becker) by raising awareness of the main Becker natural history studies that look at NSAA outcomes and other functional assessments, and to discuss how the findings in natural history studies support that functional decline can begin at any age and is irreversible.

    Más Menos
    24 m
  • Transforming Respiratory Care, Protecting Patients and Our Planet
    1 h y 6 m
  • The Obesity Puzzle in the Era of GLP-1s: Weight Loss Psychology
    Oct 20 2025

    Holly Wyatt explores the psychological side of sustained weight loss: mindset, identity shifts, and why willpower isn’t enough. Discover patterns from over 10,000 successful weight maintainers, and the first steps toward emotional resilience in obesity care.

    Timestamps:

    00:45 – Wyatt’s Journey

    03:48 – Psychological barriers

    06:09 – State of Slim

    08:06 – Successful losers

    11:16 – Advice

    Más Menos
    15 m
  • Quickfire: The Obesity Puzzle in the Era of GLP-1s
    Oct 20 2025

    In this rapid-fire episode, Holly Wyatt answers key questions on metabolism, myths, motivation, GLP-1 misconceptions, and daily health habits. Ideal for listeners seeking a fast, insightful overview of modern weight management in under 5 minutes.

    Más Menos
    4 m
  • Antimicrobial Stewardship in Children: Future of Vaccines and Antimicrobial Stewardship
    Oct 16 2025

    In the final episode of this series, Susanna Esposito explores how vaccine coverage, microbiome preservation, and emerging therapeutics intersect with antimicrobial stewardship. She also discusses innovative strategies, such as bacteriophages, microbiome-targeted therapies, and AI-driven predictive analytics, to prevent infections while optimising antibiotic use in children.

    Timestamps:

    00:00 – Introduction

    00:50 – Vaccine coverage

    02:20 – Gut–lung axis

    03:23 – Microbiome-targeted therapies

    04:37 – Bacteriophages

    05:45 – AI analytics

    06:30 – Final message

    Más Menos
    8 m